| Biosimilars Market to Witness Significant Rise in Revenue During the Forecast to 2027 |
|
| Overall healthcare costs are rising owing to the high-priced pharmaceutical drugs, particularly biologics. Government bodies worldwide are concentrating on lower-priced drug synthesis. The United States spends the most on healthcare and is therefore, |
| read more |
|
|
| Data Analysis, Storage and Management Market in Life Sciences to Witness a Healthy Growth 2027 |
|
| The global data analysis, storage & management market in life sciences is expected to register a CAGR of 12.0% during the forecast period and is expected to hit USD 43,895.69 million by 2027. Data analysis, storage, and management provi |
| read more |
|
|
| Automated Cell Culture Market to Record Significant Incremental Dollar Opportunity Forecast to 2027 |
|
| Global Automated Cell Culture Market is expected to register a CAGR of 8.18% during the forecast period and expected to hit USD 16,287.9 Million by 2027. The automation in the steps involved in cell culture has several advantages, such as reducing ti |
| read more |
|
|
| ePharmacy Market Overview with Demographic Data and Industry Growth Trends 2027 |
|
| ePharmacy is an online service that aids consumers to order medicines online and delivers them to the doorstep. Such an order can be placed through e-commerce platforms, shipping companies, or via mail. Increasing penetration of the internet, e-comme |
| read more |
|
|
| Patient Handling Equipment Market to Exhibit Significant Opportunity Assessment Forecast to 2027 |
|
| The global patient handling equipment market is predicted to develop due to an increase in the use of patient handling equipment in hospitals, rehabilitation facilities, and aged care settings. The expanding elderly population and the growing patient |
| read more |
|
|
| Neurodiagnostics Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast 2027 |
|
| Market Research Future (MRFR) confirms that the Neurodiagnostics market 2020 can procure a growth rate of 6.88% over the appraisal period (between 2019 and 2025). We will provide COVID-19 impact analysis with the report, along with all the extensive |
| read more |
|
|
